Futura Medical PLC (FAMDF)
0.41
-0.06
(-12.77%)
USD |
OTCM |
May 02, 16:00
Futura Medical Price to Book Value: 17.71 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 17.71 |
| May 01, 2024 | 20.31 |
| April 30, 2024 | 18.15 |
| April 29, 2024 | 18.15 |
| April 26, 2024 | 18.15 |
| April 25, 2024 | 16.42 |
| April 24, 2024 | 19.44 |
| April 23, 2024 | 17.28 |
| April 22, 2024 | 18.23 |
| April 19, 2024 | 18.15 |
| April 18, 2024 | 19.88 |
| April 17, 2024 | 20.74 |
| April 16, 2024 | 19.01 |
| April 15, 2024 | 18.15 |
| April 12, 2024 | 19.44 |
| April 11, 2024 | 21.60 |
| April 10, 2024 | 19.88 |
| April 09, 2024 | 21.60 |
| April 08, 2024 | 21.21 |
| April 05, 2024 | 21.17 |
| April 04, 2024 | 19.47 |
| April 03, 2024 | 20.74 |
| April 02, 2024 | 20.31 |
| April 01, 2024 | 22.90 |
| March 28, 2024 | 21.60 |
| Date | Value |
|---|---|
| March 27, 2024 | 21.60 |
| March 26, 2024 | 20.31 |
| March 25, 2024 | 20.31 |
| March 22, 2024 | 21.60 |
| March 21, 2024 | 21.60 |
| March 20, 2024 | 21.17 |
| March 19, 2024 | 22.04 |
| March 18, 2024 | 22.04 |
| March 15, 2024 | 21.60 |
| March 14, 2024 | 21.17 |
| March 13, 2024 | 21.17 |
| March 12, 2024 | 21.60 |
| March 11, 2024 | 20.74 |
| March 08, 2024 | 20.31 |
| March 07, 2024 | 20.31 |
| March 06, 2024 | 24.63 |
| March 05, 2024 | 23.76 |
| March 04, 2024 | 23.33 |
| March 01, 2024 | 22.47 |
| February 29, 2024 | 22.90 |
| February 28, 2024 | 23.76 |
| February 27, 2024 | 21.60 |
| February 26, 2024 | 20.31 |
| February 23, 2024 | 20.74 |
| February 22, 2024 | 25.92 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.189
Minimum
Jan 27 2022
942.74
Maximum
May 27 2020
73.95
Average
18.15
Median
Apr 15 2024
Price to Book Value Benchmarks
| Adaptimmune Therapeutics PLC | 7.434 |
| Biodexa Pharmaceuticals Plc | 0.8977 |
| Verona Pharma PLC | 5.061 |
| NuCana PLC | 0.4493 |
| Autolus Therapeutics PLC | 10.09 |
Price to Book Value Related Metrics
| PS Ratio | 31.29 |
| PEG Ratio | -1.472 |
| Price | 0.41 |
| Earnings Yield | -6.71% |
| Market Cap | 123.59M |
| PEGY Ratio | -1.472 |